These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30820367)

  • 1. A Major Depressive Disorder in a Patient with Pseudobulbar Affect.
    Espiridion ED; Risos KN
    Cureus; 2018 Dec; 10(12):e3746. PubMed ID: 30820367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextromethorphan/quinidine for the treatment of pseudobulbar affect.
    Patatanian E; Casselman J
    Consult Pharm; 2014 Apr; 29(4):264-9. PubMed ID: 24704895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pseudobulbar affect (PBA) in a patient with a history of traumatic brain injury, partial brain resection, and brainstem stroke: a case report.
    Young FG; Nguyen D
    J Med Case Rep; 2020 Dec; 14(1):235. PubMed ID: 33272325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crying and suicidal, but not depressed. Pseudobulbar affect in multiple sclerosis successfully treated with valproic acid: Case report and literature review.
    Johnson B; Nichols S
    Palliat Support Care; 2015 Dec; 13(6):1797-801. PubMed ID: 24916672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudobulbar Affect Presenting as Aggressive Behavior.
    Kazi SE; Anwar A
    Cureus; 2022 Feb; 14(2):e21978. PubMed ID: 35282555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions.
    Pattee GL; Wymer JP; Lomen-Hoerth C; Appel SH; Formella AE; Pope LE
    Curr Med Res Opin; 2014 Nov; 30(11):2255-65. PubMed ID: 25062507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudobulbar Affect Mimicking Depression: A Case Report.
    Kekere V; Qureshi D; Thanju A; Fouron P; Olupona T
    Cureus; 2022 Jun; 14(6):e26235. PubMed ID: 35911367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of pseudobulbar affect in a mixed neurodegenerative disorder with compounded quinidine capsules and dextromethorphan cough syrup.
    Villeneuve Y; Cruz-Santiago D; Masson H; Clerc D
    SAGE Open Med Case Rep; 2020; 8():2050313X20921076. PubMed ID: 32547756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Approach of a High Functioning Individual With Traumatic Brain Injury and Subsequent Emotional Volatility With Features of Pathological Laughter and Crying With Dextromethorphan/Quinidine.
    Garcia-Baran D; Johnson TM; Wagner J; Shen J; Geers M
    Medicine (Baltimore); 2016 Mar; 95(12):e2886. PubMed ID: 27015166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis.
    Panitch HS; Thisted RA; Smith RA; Wynn DR; Wymer JP; Achiron A; Vollmer TL; Mandler RN; Dietrich DW; Fletcher M; Pope LE; Berg JE; Miller A;
    Ann Neurol; 2006 May; 59(5):780-7. PubMed ID: 16634036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pseudobulbar affect in stroke patients in Argentina].
    Alet M; Segamarchi C; Claverie S; Gonzálezy L; Lepera S; Rey R
    Vertex; 2020 Apr; XXX(148):1-5. PubMed ID: 33890929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextromethorphan/quinidine: in pseudobulbar affect.
    Garnock-Jones KP
    CNS Drugs; 2011 May; 25(5):435-45. PubMed ID: 21476614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudobulbar Affect Presenting as Hypomania.
    Espiridion ED; Mitchell C; Kadakia S
    Cureus; 2020 Mar; 12(3):e7308. PubMed ID: 32313749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial.
    Brooks BR; Thisted RA; Appel SH; Bradley WG; Olney RK; Berg JE; Pope LE; Smith RA;
    Neurology; 2004 Oct; 63(8):1364-70. PubMed ID: 15505150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect.
    Pioro EP
    Neurol Ther; 2014 Jun; 3(1):15-28. PubMed ID: 26000221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Features and Related Factors of Poststroke Pathological Laughing and Crying: A Case-Control Study.
    Wang G; Teng F; Chen Y; Liu Y; Li Y; Cai L; Zhang X; Nie Z; Jin L
    J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):556-64. PubMed ID: 26683594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudobulbar crying induced by stimulation in the region of the subthalamic nucleus.
    Okun MS; Raju DV; Walter BL; Juncos JL; DeLong MR; Heilman K; McDonald WM; Vitek JL
    J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):921-3. PubMed ID: 15146017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mirtazapine treatment for pathological laughing and crying after stroke.
    Kim SW; Shin IS; Kim JM; Lim SY; Yang SJ; Yoon JS
    Clin Neuropharmacol; 2005; 28(5):249-51. PubMed ID: 16239769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Compounded Dextromethorphan-Quinidine Suspension for Pseudobulbar Affect in Hospice Patients.
    Wahler RG; Reiman AT; Schrader JV
    J Palliat Med; 2017 Mar; 20(3):294-297. PubMed ID: 27997281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.